Cargando…

Comparing the performance of six human papillomavirus tests in a screening population

BACKGROUND: Several new assays have been developed for high-risk HPV testing of cervical samples; we compare six HPV tests in a screening population. METHODS: Residual material from liquid-based PreservCyt samples was assayed. Four tests (Hybrid Capture 2, Cobas, Abbott and Becton-Dickinson (BD)) me...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuzick, J, Cadman, L, Mesher, D, Austin, J, Ashdown-Barr, L, Ho, L, Terry, G, Liddle, S, Wright, C, Lyons, D, Szarewski, A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2013
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590662/ https://www.ncbi.nlm.nih.gov/pubmed/23370211 http://dx.doi.org/10.1038/bjc.2013.22

Ejemplares similares

A comparison of different human papillomavirus tests in PreservCyt versus SurePath in a referral population—PREDICTORS 4
por: Cuzick, Jack, et al.
Publicado: (2016)

HPV self-sampling as an alternative strategy in non-attenders for cervical screening – a randomised controlled trial
por: Szarewski, A, et al.
Publicado: (2011)

Attitudes towards cytology and human papillomavirus self-sample collection for cervical screening among Hindu women in London, UK: a mixed methods study
por: Cadman, Louise, et al.
Publicado: (2015)

Individual detection of 14 high risk human papilloma virus genotypes by the PapType test for the prediction of high grade cervical lesions
por: Cuzick, Jack, et al.
Publicado: (2014)

Long-term follow-up of cervical disease in women screened by cytology and HPV testing: results from the HART study
por: Mesher, D, et al.
Publicado: (2010)

The expression of FHIT, PCNA and EGFR in benign and malignant breast lesions
por: Terry, G, et al.
Publicado: (2007)

Performance of cytology and human papillomavirus testing in relation to the menstrual cycle
por: Sherman, M E, et al.
Publicado: (2006)

Barriers to cervical screening in women who have experienced sexual abuse: an exploratory study
por: Cadman, Louise, et al.
Publicado: (2012)

Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting
por: Szarewski, Anne, et al.
Publicado: (2007)

Cost and logistics of alternative roll-out options for implementing human papillomavirus testing as a triage in cervical screening: results of the sentinel sites study
por: Legood, R, et al.
Publicado: (2012)

Frequency and prognostic significance of p16(INK4A) protein overexpression and transcriptionally active human papillomavirus infection in laryngeal squamous cell carcinoma
por: Young, R J, et al.
Publicado: (2015)

Human papillomavirus 16 infection in adenocarcinoma of the cervix
por: Chew, G K, et al.
Publicado: (2005)

Telomerase activity as an adjunct to high-risk human papillomavirus types 16 and 18 and cytology screening in cervical cancer
por: Kailash, U, et al.
Publicado: (2006)

High-resolution genomic profiling of human papillomavirus-associated vulval neoplasia
por: Purdie, K J, et al.
Publicado: (2010)

Correlation between human papillomavirus and p16 overexpression in oropharyngeal tumours: a systematic review
por: Grønhøj Larsen, C, et al.
Publicado: (2014)

A DNA methylation classifier of cervical precancer based on human papillomavirus and human genes
por: Brentnall, Adam R, et al.
Publicado: (2014)

Screening for colorectal cancer: random comparison of guaiac and immunochemical faecal occult blood testing at different cut-off levels
por: Hol, L, et al.
Publicado: (2009)

T-cell responses to human papillomavirus type 16 among women with different grades of cervical neoplasia
por: Steele, J C, et al.
Publicado: (2005)

Expression of LRIG1 is associated with good prognosis and human papillomavirus status in oropharyngeal cancer
por: Lindquist, D, et al.
Publicado: (2014)

Role of fine-needle aspiration cytology and core biopsy in the preoperative diagnosis of screen-detected breast carcinoma
por: Lieske, B, et al.
Publicado: (2006)

Human papillomavirus infection: an Anonymous Prevalence Study in South Wales, UK
por: Hibbitts, S, et al.
Publicado: (2006)

Human papillomavirus 16 is an aetiological factor of scrotal cancer
por: Guimerà, Núria, et al.
Publicado: (2017)

Serum sCD26 for colorectal cancer screening in family-risk individuals: comparison with faecal immunochemical test
por: Otero-Estévez, O, et al.
Publicado: (2015)

Increased expression of RRM2 by human papillomavirus E7 oncoprotein promotes angiogenesis in cervical cancer
por: Wang, N, et al.
Publicado: (2014)

A new pathological system for grading DCIS with improved prediction of local recurrence: results from the UKCCCR/ANZ DCIS trial
por: Pinder, S E, et al.
Publicado: (2010)

Mir143 expression inversely correlates with nuclear ERK5 immunoreactivity in clinical prostate cancer
por: Ahmad, I, et al.
Publicado: (2013)

Hsp-27 expression at diagnosis predicts poor clinical outcome in prostate cancer independent of ETS-gene rearrangement
por: Foster, C S, et al.
Publicado: (2009)

Human papillomavirus-16 is integrated in lung carcinomas: a study in Chile
por: Aguayo, F, et al.
Publicado: (2007)

Are there biological differences between screen-detected and interval colorectal cancers in the English Bowel Cancer Screening Programme?
por: Walsh, Elizabeth, et al.
Publicado: (2016)

HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial
por: Kitchener, H C, et al.
Publicado: (2006)

A circulating miRNA assay as a first-line test for prostate cancer screening
por: Sharova, Evgeniya, et al.
Publicado: (2016)

Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina
por: Hellman, K, et al.
Publicado: (2014)

High viral loads of human papillomavirus predict risk of invasive cervical carcinoma
por: Moberg, M, et al.
Publicado: (2005)

Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China
por: Shuyama, K, et al.
Publicado: (2007)

Human papillomavirus association is the most important predictor for surgically treated patients with oropharyngeal cancer
por: Wagner, Steffen, et al.
Publicado: (2017)

High-risk HPV type-specific clearance rates in cervical screening
por: Bulkmans, N W J, et al.
Publicado: (2007)

Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer
por: Attard, G, et al.
Publicado: (2008)

Prognostic value of PTEN loss in men with conservatively managed localised prostate cancer
por: Cuzick, J, et al.
Publicado: (2013)

Carbonic anhydrase IX (CA-IX) and high-risk human papillomavirus (H-HPV) as diagnostic biomarkers of cervical dysplasia/neoplasia in Japanese women with a cytologic diagnosis of atypical glandular cells (AGC): a Gynecologic Oncology Group (GOG) Study
por: Liao, S-Y, et al.
Publicado: (2011)

Performance of the Xpert HPV assay in women attending for cervical screening
por: Cuzick, Jack, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_4ur80arrd65jrjmneehjdemvag